Select Publications
Conference Papers
, 2025, 'IMPACT OF THE GUT MICROBIOTA ON IMMUNE MODULATION AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN HEPATOCELLULAR CARCINOMA: INSIGHTS FROM HUMAN AND PRECLINICAL MODELS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at Digestive Disease Week, CA, San Diego, 03 May 2025 - 06 May 2025
, 2025, 'A real world multi-centre study of effectiveness and safety of atezolizumab plus bevacizumab for hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 29 - 30
, 2025, 'Acute-on-chronic kidney disease in cirrhosis-a global study', in JOURNAL OF HEPATOLOGY, ELSEVIER
, 2024, 'MAJOR VARIATIONS IN 90-DAY MORTALITY POST-HOSPITAL DISCHARGE AMONG INPATIENTS WITH CIRRHOSIS: A PROSPECTIVE COHORT STUDY FOR THE CLEARED CONSORTIUM', in HEPATOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Diego, pp. S1970 - S1973, presented at The Liver Meeting, CA, San Diego, 15 November 2024 - 19 November 2024
, 2024, 'Portal vein thrombosis increases short-term mortality independent of liver disease severity score among hospitalized patients of decompensated cirrhosis-result from CLEARED consortium', in JOURNAL OF HEPATOLOGY, ELSEVIER, ITALY, Milan, pp. S161 - S162, presented at European-Association-for-the-Study-of-the-Liver Congress (EASL), ITALY, Milan, 05 June 2024 - 08 June 2024
, 2024, 'The liver toolkit - an innovative IT solution to screen patients in general practice for undiagnosed cirrhosis', in INTERNATIONAL JOURNAL OF INTEGRATED CARE, UBIQUITY PRESS LTD, http://dx.doi.org/10.5334/ijic.APIC3201
, 2023, ' Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A16 - A16, presented at International Digestive Disease Forum (IDDF), PEOPLES R CHINA, Hong Kong, 10 June 2023 - 11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-IDDF.6
, 2023, ' Shifting patterns of hepatocellular carcinoma mortality risk: the impact of socioeconomic status and ethnicity in NSW, australia', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A21 - A22, presented at International Digestive Disease Forum (IDDF), PEOPLES R CHINA, Hong Kong, 10 June 2023 - 11 June 2023, http://dx.doi.org/10.1136/gutjnl-2023-IDDF.11
, 2022, '10 GHz Compact Shunt-Diode Rectifier Circuit Using Thin Film Ag/AZO Schottky Barrier Diode for Energy Harvesting Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 436 - 445, http://dx.doi.org/10.1007/978-3-031-05014-5_36
, 2022, 'A 2 × 2 Array Antenna for Multi-band Energy Harvesting for Biomedical Sensing Applications', in Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics, pp. 462 - 471, http://dx.doi.org/10.1007/978-3-031-05014-5_38
, 2021, 'CONTRIBUTION OF NON-VIRAL AETIOLOGIES OF LIVER DISEASE TO THE GROWING BURDEN OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES', in HEPATOLOGY, WILEY, pp. 628A - 628A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'DISPARITIES IN OUTCOMES OF HEPATOCELLULAR CARCINOMA IN NEW SOUTH WALES BY SOCIOECONOMIC STATUS', in HEPATOLOGY, WILEY, pp. 634A - 635A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'METABOLIC RISK FACTORS ARE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER SURGICAL RESECTION', in HEPATOLOGY, WILEY, pp. 658A - 658A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188003152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Contribution of non-viral etiologies of liver disease to the growing burden of hepatocellular carcinoma in New South Wales', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 53 - 54, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Disparities in outcomes of hepatocellular carcinoma in New South Wales by socioeconomic status', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 17 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Metabolic risk factors are predictive of hepatocellular carcinoma recurrence after surgical resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 49 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Role of metabolic syndrome in persistently elevated alanine aminotransferase levels in patients with suppressed hepatitis B infection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Community screening identifies undiagnosed chronic liver disease in high-risk populations', in Journal of Gastroenterology and Hepatology Australia, pp. 2255 - 2260, http://dx.doi.org/10.1111/jgh.15473
, 2020, 'SELECTIVE INTERNAL RADIATION THERAPY FOR HEPATOCELLULAR CARCINOMA IN AUSTRALIA - A 15-YEAR MULTICENTER COHORT STUDY.', in HEPATOLOGY, WILEY, ELECTR NETWORK, pp. 706A - 707A, presented at Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), ELECTR NETWORK, 13 November 2020 - 16 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000574027002307&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Selective internal radiation therapy for hepatocellular carcinoma in Australia: A 15-year multicenter cohort study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Underlying non-alcoholic fatty liver disease increases the risk of hepatocellular carcinoma recurrence after curative hepatic resection', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 62 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'High rates of sustained virological response at 12 weeks in a real-world hospital-based cohort of direct-acting antiviral-treated patients with hepatitis C virus (HCV): The Observational, Prospective Epidemiological Registry in Australia of HCV (OPERA-C)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'How to manage pemphigus with pre-existing hepatitis B who needs rituximab therapy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467967200098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Burden of disease in patients with advanced cirrhosis not suitable for transplant', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Response to mycophenolate mofetil in patients with autoimmune hepatitis who fail standard therapy is predicted by serum gammaglobulin levels but not by cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'RESPONSE TO MYCPHENOLATE MOFETIL IN PATENTS WITH AUTOIMMUNE HEPATITIS WHO FAIL STANDARD THERAPY IS PREDICTED BY SERUM GAMMAGLOBULIN LEVELS BUT NOT CIRRHOSIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S1213 - S1213, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018
, 2018, 'Regional variability in the etiology of hepatocellular carcinoma: Opportunities for targeted interventions', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 16 - 16
, 2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089801129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'High rates of undiagnosed viral hepatitis and chronic liver disease in the community: A community-based study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Impact of a multidisciplinary team on surgical outcomes for patients undergoing curative surgery for hepatocellular carcinoma: A single-center experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S521 - S521, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31444-7
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV Genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL Study', in HEPATOLOGY, WILEY, MA, Boston, pp. 483A - 484A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Frequency and severity of biochemical abnormalities with paritaprevir/ritonavir/ombitasvir +/- ribavirin in a real-world cohort of HCV Genotype 1 patients - predictors and clinical significance', in HEPATOLOGY, WILEY, MA, Boston, pp. 442A - 442A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Mycophenolate Mofetil in Autoimmune Hepatitis Patients not Responsive or Intolerant to Standard Therapy: the Australian TAPESTRY study', in HEPATOLOGY, WILEY, MA, Boston, pp. 817A - 817A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus Ribavirin', in HEPATOLOGY, WILEY, MA, Boston, pp. 455A - 456A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Excellent SVR12 rates with Viekira Pak in a real-world cohort of HCV genotype 1 patients predominantly with cirrhosis - the Australian REV1TAL study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Frequency and severity of hyperbilirubinaemia with Viekira Pak in a real-world cohort of HCV genotype 1 patients - Predictors and clinical significance', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Mycophenolate in autoimmune hepatitis not responsive or intolerant to standard therapy: the TAPESTRY study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 100 - 101, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'General practitioners face significant barriers to prescribing direct-acting antiviral therapy for hepatitis C', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 81 - 81
, 2016, 'Reliance on specialist care in the early roll-out of direct-acting antiviral therapy for hepatitis C', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 83 - 84
, 2015, 'C-SCAPE: EFFICACY AND SAFETY OF 12 WEEKS OF GRAZOPREVIR plus /- ELBASVIR plus /- RIBAVIRIN IN PATIENTS WITH HCV GT2, 4, 5 OR 6 INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S619 - S619, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)30974-0
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 806A - 806A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483803306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Factors associated with medication adherence in patients living with cirrhosis', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 334A - 334A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483801201&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'The Protease Fibroblast Activation Protein (FAP) in Liver Disease', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 592A - 592A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483802309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Effect of metabolic syndrome on patients with viral hepatitis treated with local regional therapy for hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 78 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'The protease fibroblast activation protein (FAP) in liver disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'P427 POTENTIAL IMPACT OF IMPROVED TREATMENT ON DISEASE BURDEN OF CHRONIC HEPATITIS C IN AUSTRALIA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s210, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/s0168-8278(14)60589-4
, 2013, 'Impaired T cell glucose metabolism during chronic hepatitis C virus infection', in Narci T (ed.), Journal of Gastroenterology and Hepatology, Wiley Online, Melbourne, Australia, pp. 171 - 171, presented at Australian Gastroenterology Week 2013, Melbourne, Australia, 07 October 2013 - 09 October 2013, http://dx.doi.org/10.1111/jgh.12365_14
, 2013, 'Hepatitis C patients with hepatocellular carcinoma undergoing transarterial chemoembolisation', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 64 - 64
, 2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1